Professor Meghan Morrissey earns an innovation award to program immune cells to attack cancer tumors. #immunotherapy ...

The duo were the first researchers to identify the disease-specific reprogramming of macrophages in cancer. TAMs are the most abundant immune cell in many types of cancer and modulating their ...

Carisma Therapeutics is developing a unique, differentiated immuno-oncology (IO) treatment for solid tumors based on chimeric antigen receptor macrophages (CAR-M). Current IO treatments have ...

They found that T cell presence showed no consistent trends to viral stimulation or tumor response before and after the treatment, but there was a heavy infiltration of macrophages after treatment ...

According to research, PSAT1, PSRC1, COLEC12, HP, and PLLP may play a role in small cell lung cancer metabolism, immune ...

Pavlov's macrophages Bond stimulated engineered macrophages with light, then made the cells wait for different periods of ...

Innovative muscle patches derived from stem cells demonstrate efficacy in heart repair, improving function in primates and a ...

This important study provides solid evidence to support the anti-tumor potential of citalopram, originally an anti-depression drug, in hepatocellular carcinoma (HCC). In addition to their previous ...

Basal cell carcinomas, the most common form of skin cancer, occur in chronically sun-exposed areas such as the face. Locally ...

A research team has investigated a new combination therapy against cancer. This therapy employs systemic administration of the tissue hormone interferon-I combined with local application of Imiquimod.